MMSI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Merit Medical Systems, Inc.

Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.
CEO
Fred Lampropoulos
Employees
5989
Headquarters

1600 W Merit Pkwy
South Jordan, Utah 84095-2416
Phone: 18012531600
www.merit.com

News

Merit Medical Launches the Aspira® Evacuated Drainage Bottle | MMSI Stock News
Sep 06, 2023 14:25pm

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology,


Source:Stock Titan
Merit Medical Launches the Aspira Evacuated Drainage Bottle
Sep 06, 2023 13:25pm

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients SOUTH JORDAN, Utah, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of its Aspira Bottle. The new evacuated drainage


Source:Wallstreet:Online
Merit Medical Launches the Aspira® Evacuated Drainage Bottle
Sep 06, 2023 13:25pm

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients


Source:GlobeNewswire
Merit Medical: Soft Expectations, Capital Productivity Into FY2023 (Rating Downgrade)
Aug 29, 2023 06:38am

Merit Medical Systems has been impacted by recent acquisitions and Q2 numbers. Click here to find out why MMSI stock is a Hold.


Source:Seeking Alpha
Merit Medical Systems Inc Completes Enrollment in Groundbreaking WAVE Study for Arteriovenous Access Treatment
Aug 03, 2023 14:41pm

On August 3, 2023, Merit Medical Systems, Inc. proudly announced the successful completion of enrollment in its groundbreaking WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. This remarkable study, known as WAVE, is a one-of-a-kind, prospective, randomized, controlled, multicenter study that aims to compare the revolutionary Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) with the traditional balloon angioplasty […] The post Merit Medical Systems Inc Completes Enrollment in Groundbreaking WAVE Study for Arteriovenous Access Treatment appeared first on Best Stocks .


Source:Best Stocks
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment | MMSI Stock News
Aug 03, 2023 14:25pm

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced


Source:Stock Titan
Merit Medical''s WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
Aug 03, 2023 13:26pm

https://www.investing.com/news/assorted/merit-medicals-wrapsody-arteriovenous-access-efficacy-wave-pivotal-study-completes-enrollment-432SI-3143991


Source:Investing.com
Merit Medical’s WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
Aug 03, 2023 13:25pm

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable


Source:Wallstreet:Online
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
Aug 03, 2023 13:25pm

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) to percutaneous transluminal angioplasty for treatment of stenosis/occlusion in the venous outflow circuit in patients undergoing hemodialysis.


Source:GlobeNewswire
Amalgamated Bank Makes Startling Reduction in Stake in Merit Medical Systems
Aug 01, 2023 12:18pm

In a dramatic move that has sent waves through the financial sector, Amalgamated Bank has significantly reduced its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI). This surprising development was revealed in the bank’s Form 13F filing with the Securities and Exchange Commission (SEC) for the first quarter of this year, marking yet another noteworthy event […] The post Amalgamated Bank Makes Startling Reduction in Stake in Merit Medical Systems appeared first on Best Stocks .


Source:Best Stocks